Trinidad Montero-Melendez Selected Research

N- (3- (1- (2- nitrophenyl)- 1H- pyrrol- 2- yl)allylidenamino)guanidine

4/2015

Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Trinidad Montero-Melendez Research Topics

Disease

15	Inflammation (Inflammations) 03/2022 - 01/2011
6	Arthritis (Polyarthritis) 01/2017 - 04/2011
5	Peritonitis 07/2015 - 07/2011
3	Obesity 03/2022 - 02/2013
3	Rheumatoid Arthritis 03/2022 - 04/2011
3	Joint Diseases (Joint Disease) 01/2017 - 01/2011
2	Experimental Arthritis 01/2013 - 01/2012
1	Fibrosis (Cirrhosis) 03/2022
1	Multiple Sclerosis 03/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Synovitis 01/2017
1	Colitis 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Pleurisy (Pleuritis) 01/2017
1	Infections 12/2016
1	Alveolar Bone Loss 12/2016
1	Periodontal Diseases (Periodontal Disease) 08/2014
1	Sepsis (Septicemia) 01/2014
1	Hypothermia 01/2014
1	Blister (Bulla) 08/2013
1	Osteitis 01/2012
1	Psoriatic Arthritis 04/2011
1	Gout 04/2011
1	Gouty Arthritis 04/2011
1	Reperfusion Injury 01/2011

Drug/Important Bio-Agent (IBA)

7	MelanocortinsIBA 03/2022 - 01/2011
6	Peptides (Polypeptides)IBA 12/2016 - 01/2011
3	CytokinesIBA 01/2021 - 04/2011
3	Melanocortin Receptors (Melanocortin Receptor)IBA 08/2014 - 01/2011
2	Pharmaceutical PreparationsIBA 03/2022 - 04/2011
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2015 - 04/2011
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 08/2014 - 01/2013
2	LipidsIBA 01/2014 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 08/2013 - 01/2013
2	ZymosanIBA 01/2013 - 07/2011
2	Uric Acid (Urate)IBA 01/2012 - 04/2011
1	setmelanotideIBA 03/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	butyramideIBA 01/2017
1	Butyrates (Butyrate)IBA 01/2017
1	CarrageenanIBA 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	Fenoprofen (Fenoprofen Calcium)FDA LinkGeneric 01/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2017
1	SodiumIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2015
1	N- (3- (1- (2- nitrophenyl)- 1H- pyrrol- 2- yl)allylidenamino)guanidineIBA 04/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2014
1	Hormones (Hormone)IBA 08/2014
1	Melanocyte-Stimulating Hormones (MSH)IBA 08/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 02/2013
1	Galectins (Galectin)IBA 02/2013
1	GlucocorticoidsIBA 01/2013
1	ChemokinesIBA 01/2013
1	Annexin A1IBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012
1	Biological ProductsIBA 01/2012
1	Interleukin-1 (Interleukin 1)IBA 04/2011

Therapy/Procedure

5	Therapeutics 04/2021 - 04/2011
1	Percutaneous Coronary Intervention 01/2021
1	Intra-Articular Injections 01/2017